G1 targets cancer

G1 targets cancer

Image 2 of 2

« Previous image

A graphic in G1's IPO filing explains in part how its technology works.

Go back to reading “RTP's G1 Therapeutics goes public with $105M IPO”

LTW Partners

Techwire Inside Partners